Align Technology, Inc.（ALGN）のニュースとイベントALGNAlign Technology, Inc.

Align Technology Announces Patent Infringement Ruling

Align Technology (ALGN) announces the decision of the Unified Patent Court, UPC, finding that aligner systems incorporating Angelalign's (AGLFF) Torque Ridges feature infringe Align's European Patent EP 2 237 738 B1, which relates to Align's Power Ridge technology. In August 2025, Align initiated patent infringement proceedings against several companies within the Angelalign Technology corporate group in multiple jurisdictions, including before the UPC, which covers participating European Union member states.

Stock Futures Point to Modestly Lower Open as Investors Take a Breather

Stock futures are pointing to a modestly lower open Monday as investors take a breather following last week's record highs, while elevated Treasury yields continue to pressure equities. The 10-year Treasury yield is around 5.28%, near multiyear highs.The market is also digesting Friday's weaker-than-expected September jobs report, which reduced expectations for another Fed rate hike this month. Traders now see roughly an 80% probability that the Fed holds rates steady in October, although a December hike remains largely priced in.Brent is hovering around $102 a barrel and WTI near $90. Rising Middle East crude exports and the G7's decision to release 100M barrels from emergency reserves are helping ease some supply concerns, but the ongoing U.S.-Israeli war with Iran and attacks on Gulf energy infrastructure continue to keep crude prices elevated.The main focus this week will be the Federal Reserve's September meeting minutes, due Wednesday, which could offer clues about how policymakers viewed the inflationary impact of higher energy prices and the possibility of another rate increase later this year. Investors will also watch speeches from Fed officials for additional guidance on the policy outlook.In pre-market trading, S&P 500 futures were down 0.08%, Nasdaq futures fell 0.22% and Dow futures fell 0.05%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -PTCup 35% after Schneider Electricannounced a deal to acquire PTC for $205 per share in cashRXO Inc.up 22% after entering a pact under which C.H. Robinsonwill acquire the company in a stock-and-cash transaction for an implied value of $5.8BCerebras Systemsup 5% after OpenAI CEO Sam Altman posted on X, "Cerebras is a close partner, and we have a deep engagement pushing on the frontiers of speed."DraftKingsup 4% after BofA upgraded shares to Buy with an unchanged price target of $27Wells Fargoup 2% after Morgan Stanley upgraded the stock to Overweight with an unchanged price target of $102LOWER -Cenovus Energydown 2% after an arrangement agreement to acquire Athabasca Oil Corporation in a cash and stock transaction with an implied enterprise value of $5.7BAlign Technologydown 2% after Evercore ISI downgraded shares to In Line from Outperform with a price target of $155, down from $220C.H. Robinsondown 14% after its deal to buy RXO

Align Wins Patent Infringement Case in China, Awarded RMB 10M

Align Technology announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China. In September 2025, Align filed a patent infringement action against Angel in the Jinan Intermediate People's Court, asserting Align's patent related to extraction-gap-closure technology. On August 10, the Jinan Intermediate People's Court issued a first-instance judgment finding that Angel's use of its MasterForce biomechanical simulation system and ATreat digital orthodontic treatment design system to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align's patent rights. The court further found that the related aligner products manufactured and sold using the accused technology also infringe Align's patent. Angel may appeal the judgment to the Supreme People's Court. The deadline for filing an appeal has not yet expired. The court ordered Angel to cease using the patented technology and to stop manufacturing and selling the infringing products in China and awarded Align RMB 10M in damages. While the ruling remains subject to appeal, Align believes the decision further reinforces the strength of its intellectual property portfolio and ongoing commitment to protecting its innovations globally. The ruling follows other recent developments in Align's patent-enforcement actions against Angel. In February, the Unified Patent Court issued a preliminary injunction requiring Angel to cease infringement of Align's patented ClinCheck Live Update technology, a decision that was subsequently upheld on appeal. In July 2026, the U.S. International Trade Commission conducted an evidentiary hearing concerning five patents asserted by Align against Angel. Align expects that the ITC will make its initial determination regarding the merits of Align's claims in November. Align also continues to pursue additional patent infringement actions against Angel affiliates in China and Europe.